REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF FOR IN-VIVO REPLICATION AND PATHOGENICITY

被引:198
|
作者
JAMIESON, BD
ALDROVANDI, GM
PLANELLES, V
JOWETT, JBM
GAO, LY
BLOCH, LM
CHEN, ISY
ZACK, JA
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024
关键词
D O I
10.1128/JVI.68.6.3478-3485.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of human immunodeficiency virus type 1 (HIV-1) accessory genes in pathogenesis has remained unclear because of the lack of a suitable in vivo model. The most controversial of these genes is nef. We investigated the requirement for Nef for in vivo replication and pathogenicity of two isolates of HIV-1 (HIV-1(JR-CSF) and HIV-1(NL+3)) in human fetal thymus and liver implants in severe combined immunodeficient mice. HIV-1(JR-CSF) and HIV-1(NL4-3) differ in their in vitro phenotypes in that HIV-1(JR-CSF) does not induce syncytia and is relatively noncytopathic, while HIV-1(NL4-3) is highly cytopathic and readily inducers syncytia. The nef mutants of both isolates grew with kinetics similar to those of parental virus strains in stimulated peripheral blood Iymphocytes but demonstrated attenuated growth properties in vivo. HIV-1(NL4-3) induced severe depletion of human thymocytes within 6 necks of infection, whereas its nef mutant did not. Thus, HIV-1 Nef is required for efficient in vivo viral replication and pathogenicity.
引用
下载
收藏
页码:3478 / 3485
页数:8
相关论文
共 50 条
  • [1] EFFECT OF NEF ALLELES ON REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ZAZOPOULOS, E
    HASELTINE, WA
    VIROLOGY, 1993, 194 (01) : 20 - 27
  • [2] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF GENE-SEQUENCES PRESENT IN-VIVO
    SHUGARS, DC
    SMITH, MS
    GLUECK, DH
    NANTERMET, PV
    SEILLIERMOISEIWITSCH, F
    SWANSTROM, R
    JOURNAL OF VIROLOGY, 1993, 67 (08) : 4639 - 4650
  • [3] ALLELIC VARIATION IN THE EFFECTS OF THE NEF GENE ON REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TERWILLIGER, EF
    LANGHOFF, E
    GABUZDA, D
    ZAZOPOULOS, E
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10971 - 10975
  • [4] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER INSERTION IN-VIVO
    RAINERI, I
    SOLER, M
    SENN, HP
    VIROLOGY, 1995, 208 (01) : 359 - 364
  • [5] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
  • [6] THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MAKONKAWKEYOON, S
    LIMSONPOBRE, RNR
    MOREIRA, AL
    SCHAUF, V
    KAPLAN, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 5974 - 5978
  • [7] ANTIVIRAL STRATEGIES IN THE REPLICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    WAINBERG, MA
    BOUR, S
    GELEZIUNAS, R
    BENTWICH, Z
    UNION MEDICALE DU CANADA, 1992, 121 (05): : 307 - &
  • [8] IN-VIVO PATHOGENIC PROPERTIES OF 2 CLONAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    JAMIESON, BD
    PANG, S
    ALDROVANDI, GM
    ZHA, JL
    ZACK, JA
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6259 - 6264
  • [9] DYNAMICS OF MOLECULAR-PARAMETERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VIVO
    BAGNARELLI, P
    VALENZA, A
    MENZO, S
    MANZIN, A
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    JOURNAL OF VIROLOGY, 1994, 68 (04) : 2495 - 2502
  • [10] MUTATIONAL ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ELI NEF FUNCTION
    ZAZOPOULOS, E
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6634 - 6638